Page last updated: 2024-12-06

menthone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Occurs in Manufacturing Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Menthone is a cyclic ketone found in peppermint oil and other essential oils. It is a colorless liquid with a strong minty odor. Menthone is synthesized through the oxidation of menthol, a process often involving chromic acid. It has various applications, including its use as a flavoring agent in foods and beverages, a fragrance component in cosmetics and perfumes, and a pharmaceutical ingredient. Menthone is studied for its potential therapeutic properties, such as its anti-inflammatory and analgesic effects. It is also a common model compound for studying the chemistry of terpenoids. '

menthone : The trans-stereoisomer of p-menthan-3-one. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

(-)-menthone : A menthone that is cyclohexanone substituted by a methyl and an isopropyl group at positions 5 and 2 respectively (the 2S,5R-stereoisomer). [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID26447
CHEMBL ID276311
CHEBI ID15410
SCHEMBL ID21709
MeSH IDM0071937

Synonyms (125)

Synonym
(2s,5r)-5-methyl-2-(1-methylethyl)cyclohexanone
(1r,4s)-p-menthan-3-one
CHEBI:15410 ,
(2s,5r)-2-isopropyl-5-methylcyclohexanone
(2s,5r)-5-methyl-2-(propan-2-yl)cyclohexanone
(2s-trans)-5-methyl-2-(1-methylethyl)cyclohexanone
cyclohexanone, 5-methyl-2-(1-methylethyl)-, trans-
p-menthan-3-one, trans-
KBIO1_001477
DIVK1C_006533
SDCCGMLS-0066582.P001
(-)-5-methyl-2-(1-methylethyl)cyclohexanone
(-)-(2s,5r)-menthone
trans-p-menthan-3-one
p-menthan-3-one, dl-
ai3-11106
5-methyl-2-(1-methylethyl)cyclohexanone, trans-
menthone racemic
einecs 201-941-1
p-menthone
trans-menthone
p-menthan-3-one racemic
cyclohexanone, 5-methyl-2-(1-methylethyl)-, trans-(+/-)-
hsdb 1268
menthone (natural)
neomenthone
dl-menthone
ccris 5747
cyclohexan-1-one, 2-isopropyl-5-methyl-, racemic
(dl)-menthone
cyclohexanone, 5-methyl-2-(1-methylethyl)-, (2r,5s)-rel-
SPECTRUM_001299
trans-menthan-3-one
einecs 214-049-2
SPECTRUM4_001648
fema no. 2667
SPECTRUM5_000495
BSPBIO_002864
NCGC00178425-01
menthone
cyclohexanone, 5-methyl-2-(1-methylethyl)-, (2s,5r)-
inchi=1/c10h18o/c1-7(2)9-5-4-8(3)6-10(9)11/h7-9h,4-6h2,1-3h3/t8-,9+/m1/s
rel-(2r,5s)-2-isopropyl-5-methylcyclohexanone
(-)-menthone
C00843
14073-97-3
l-menthone
(2s,5r)-2-isopropyl-5-methyl-cyclohexanone
(-)-menthone, 90%
NCGC00095606-01
KBIO3_002364
KBIOSS_001779
KBIOGR_002115
KBIO2_001779
KBIO2_004347
KBIO2_006915
SPECTRUM2_000691
SPBIO_000841
SPECPLUS_000437
SPECTRUM3_001272
SPECTRUM300564
89-80-5
(-)-(1r,4s)-menthone
LMPR0102090004
1/c10h18o/c1-7(2)9-5-4-8(3)6-10(9)11/h7-9h,4-6h2,1-3h3/t8-,9+/m1/s
l-menthan-3-one
BMSE000375
cyclohexanone, 5-methyl-2-(1-methylethyl)-, (2s-trans)-
CHEMBL276311
(1r,4s)-(-)-p-menthan-3-one
(2s,5r)-5-methyl-2-propan-2-ylcyclohexan-1-one
(2s,5r)-5-methyl-2-(propan-2-yl)cyclohexan-1-one
9nh5j4v8fn ,
unii-9nh5j4v8fn
unii-5f709w4og4
einecs 237-926-1
5f709w4og4 ,
ec 237-926-1
tox21_302153
NCGC00255957-01
cas-14073-97-3
dtxcid1024384
dtxsid3044384 ,
tox21_111510
AKOS006343213
CCG-38562
menthone, (-)-
menthone g
1-methyl-4-isopropylcyclohexan-3-one
l-menthone [mi]
menthone [fhfi]
(-)-menthone [fcc]
menthone, l-
trans-p-menthone
SCHEMBL21709
tox21_111510_1
NCGC00095606-02
1-menthone
(-)menthone
(2s,5r)2-isopropyl-5-methylcyclohexanone
(2s,5r)-2-isopropyl-5-methylcyclohexan-1-one
DTXSID2044478
W-108194
(2s,5r)-5-methyl-2-(1-methylethyl)-cyclohexanone
2-isopropyl-5-methylcyclohexanone, trans
menthon
cyclohexanone, 5-methyl-2-(1-methylethyl)-, trans-(.+/-.)-
menthan-3-one, trans
mfcd00001634
mfcd00136033
SR-05000002387-1
sr-05000002387
(-)-menthone, primary pharmaceutical reference standard
(-)-menthone, analytical standard
5-methyl-2-(1-methylethyl)-(2s,5r)-cyclohexanone
5-methyl-2-(1-methylethyl)-(2s-trans)-cyclohexanone
(2s, 5r)-trans-2-isopropyl-5-methylcyclohexanone
(1s)-trans-p-menthan-3-one
(-)-menthone,(s)
AS-17440
Q424902
EN300-383879
CS-0138798
HY-N7916
Z1201619246

Research Excerpts

Overview

L-Menthone (MTN) is a Chinese old remedy extracted from the genus Mentha.

ExcerptReferenceRelevance
"L-Menthone (MTN) is a Chinese old remedy extracted from the genus Mentha. "( L-Menthone confers antidepressant-like effects in an unpredictable chronic mild stress mouse model via NLRP3 inflammasome-mediated inflammatory cytokines and central neurotransmitters.
Deng, X; Fu, Q; Li, H; Ma, S; Ma, Z; Xue, J, 2015
)
1.86

Toxicity

ExcerptReferenceRelevance
"1-fold more toxic than menthol to the rice weevil."( Fumigant toxicity of volatile natural products from Korean spices and medicinal plants towards the rice weevil, Sitophilus oryzae (L).
Campbell, BC; Choi, WS; Kim, JG; Lee, BH; Lee, SE; Park, BS, 2001
)
0.31
"55 µg per adult respectively) and was more toxic than menthone (7 day LD(50)=33."( Toxicity of Schizonpeta multifida essential oil and its constituent compounds towards two grain storage insects.
Chu, SS; Jiang, GH; Liu, ZL, 2011
)
0.62
" There was no mortality, adverse effects on general conditions or changes in body weight, food consumption and feed conversion efficiency throughout the study in male and female rats."( Safety assessment of essential oil from Minthostachys verticillata (Griseb.) Epling (peperina): 90-days oral subchronic toxicity study in rats.
Bagnis, G; Cariddi, LN; Cavaglieri, LR; Cristofolini, A; Escobar, FM; Gallucci, MN; Mañas, F; Sabini, LI; Sabini, MC, 2015
)
0.42

Bioavailability

ExcerptReferenceRelevance
"The ATP-binding cassette transporter P-glycoprotein (P-gp) is known to limit both brain penetration and oral bioavailability of many chemotherapy drugs."( A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
Ambudkar, SV; Brimacombe, KR; Chen, L; Gottesman, MM; Guha, R; Hall, MD; Klumpp-Thomas, C; Lee, OW; Lee, TD; Lusvarghi, S; Robey, RW; Shen, M; Tebase, BG, 2019
)
0.51

Dosage Studied

ExcerptRelevanceReference
" To test this hypothesis, male and female rats were dosed orally with 14C-labeled pulegone (80 mg/kg, 120 microCi/kg) or menthofuran (60 mg/kg, 120 microCi/kg) or menthones (80 mg/kg, 120 microCi/kg) in corn oil, and the kidney cytosol was prepared 24 h after dosing."( 14C-labeled pulegone and metabolites binding to alpha2u-globulin in kidneys of male F-344 rats.
Borghoff, SJ; Burka, LT; Ferguson, LJ; Lebetkin, EH; Lih, FB; Parkinson, HD; Tomer, KB, 2007
)
0.54
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Occurs in Manufacturing (1 Product(s))

Product Categories

Product CategoryProducts
Beauty & Personal Care1

Products

ProductBrandCategoryCompounds Matched from IngredientsDate Retrieved
Derma E Keratin Thickening Spray -- 3.35 fl ozDerma EBeauty & Personal Carebiotin, caffeine, fructose, panthenol, provitamin B5, ethylhexylglycerin, glycerin, hydroxyethylcellulose, menthol, menthone2024-11-29 10:47:42

Drug Classes (1)

ClassDescription
menthoneThe trans-stereoisomer of p-menthan-3-one.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (2)

PathwayProteinsCompounds
Monoterpenoid Biosynthesis618
menthol biosynthesis821

Protein Targets (8)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
RAR-related orphan receptor gammaMus musculus (house mouse)Potency34.44400.006038.004119,952.5996AID1159521
GLI family zinc finger 3Homo sapiens (human)Potency17.01470.000714.592883.7951AID1259369; AID1259392
AR proteinHomo sapiens (human)Potency29.84930.000221.22318,912.5098AID1259243
progesterone receptorHomo sapiens (human)Potency76.95880.000417.946075.1148AID1346795
glucocorticoid receptor [Homo sapiens]Homo sapiens (human)Potency6.00700.000214.376460.0339AID720692
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency54.48270.003041.611522,387.1992AID1159552; AID1159555
retinoid X nuclear receptor alphaHomo sapiens (human)Potency61.64480.000817.505159.3239AID1159527
heat shock protein beta-1Homo sapiens (human)Potency48.96620.042027.378961.6448AID743228
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (68)

Assay IDTitleYearJournalArticle
AID1347083qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: Viability assay - alamar blue signal for LASV Primary Screen2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347103qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for OHS-50 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1745845Primary qHTS for Inhibitors of ATXN expression
AID1347093qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SK-N-MC cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347102qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh18 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347424RapidFire Mass Spectrometry qHTS Assay for Modulators of WT P53-Induced Phosphatase 1 (WIP1)2019The Journal of biological chemistry, 11-15, Volume: 294, Issue:46
Physiologically relevant orthogonal assays for the discovery of small-molecule modulators of WIP1 phosphatase in high-throughput screens.
AID1296008Cytotoxic Profiling of Annotated Libraries Using Quantitative High-Throughput Screening2020SLAS discovery : advancing life sciences R & D, 01, Volume: 25, Issue:1
Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening.
AID1347089qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for TC32 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347407qHTS to identify inhibitors of the type 1 interferon - major histocompatibility complex class I in skeletal muscle: primary screen against the NCATS Pharmaceutical Collection2020ACS chemical biology, 07-17, Volume: 15, Issue:7
High-Throughput Screening to Identify Inhibitors of the Type I Interferon-Major Histocompatibility Complex Class I Pathway in Skeletal Muscle.
AID1347091qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SJ-GBM2 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347105qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for MG 63 (6-TG R) cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347101qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for BT-12 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347106qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for control Hh wild type fibroblast cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347092qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for A673 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347100qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for LAN-5 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347082qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: LASV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347094qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for BT-37 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347098qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SK-N-SH cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347108qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh41 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347096qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for U-2 OS cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347099qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for NB1643 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347097qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Saos-2 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347425Rhodamine-PBP qHTS Assay for Modulators of WT P53-Induced Phosphatase 1 (WIP1)2019The Journal of biological chemistry, 11-15, Volume: 294, Issue:46
Physiologically relevant orthogonal assays for the discovery of small-molecule modulators of WIP1 phosphatase in high-throughput screens.
AID1347086qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lymphocytic Choriomeningitis Arenaviruses (LCMV): LCMV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347104qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for RD cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID1347107qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh30 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1508630Primary qHTS for small molecule stabilizers of the endoplasmic reticulum resident proteome: Secreted ER Calcium Modulated Protein (SERCaMP) assay2021Cell reports, 04-27, Volume: 35, Issue:4
A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome.
AID1347090qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for DAOY cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347095qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for NB-EBc1 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347154Primary screen GU AMC qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1346986P-glycoprotein substrates identified in KB-3-1 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1346987P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1866870Antiarthritic activity against collagen-II induced rheumatoid arthritis DBA-1 mouse model assessed as reduction in IL-17 protein level at 100 mg/kg administered for 14 days on day 60 to day 74 post-immunization by immunohistochemistry analysis2022Journal of natural products, 04-22, Volume: 85, Issue:4
A Natural Plant Ingredient, Menthone, Regulates T Cell Subtypes and Lowers Pro-inflammatory Cytokines of Rheumatoid Arthritis.
AID1866847Antiarthritic activity against collagen-II induced rheumatoid arthritis DBA-1 mouse model assessed as reduction in serum IL-6 level at 100 mg/kg administered for 14 days on day 60 to day 74 post-immunization by ELISA2022Journal of natural products, 04-22, Volume: 85, Issue:4
A Natural Plant Ingredient, Menthone, Regulates T Cell Subtypes and Lowers Pro-inflammatory Cytokines of Rheumatoid Arthritis.
AID1866846Antiarthritic activity against collagen-II induced rheumatoid arthritis DBA-1 mouse model assessed as reduction in serum IL-1beta level at 100 mg/kg administered for 14 days on day 60 to day 74 post-immunization by ELISA2022Journal of natural products, 04-22, Volume: 85, Issue:4
A Natural Plant Ingredient, Menthone, Regulates T Cell Subtypes and Lowers Pro-inflammatory Cytokines of Rheumatoid Arthritis.
AID1866861Antiarthritic activity against collagen-II induced rheumatoid arthritis DBA-1 mouse spleen CD4+ T cells assessed as reduction in T-bet mRNA level at 100 mg/kg administered for 14 days on day 60 to day 74 post-immunization by RT-qPCR assay2022Journal of natural products, 04-22, Volume: 85, Issue:4
A Natural Plant Ingredient, Menthone, Regulates T Cell Subtypes and Lowers Pro-inflammatory Cytokines of Rheumatoid Arthritis.
AID1866853Antiarthritic activity against collagen-II induced rheumatoid arthritis DBA-1 mouse blood CD4+ T cells assessed as reduction in Th1 cells differentiation at 100 mg/kg administered for 14 days on day 60 to day 74 post-immunization by flow cytometry analysi2022Journal of natural products, 04-22, Volume: 85, Issue:4
A Natural Plant Ingredient, Menthone, Regulates T Cell Subtypes and Lowers Pro-inflammatory Cytokines of Rheumatoid Arthritis.
AID1866863Antiarthritic activity against collagen-II induced rheumatoid arthritis DBA-1 mouse spleen CD4+ T cells assessed as increase in GATA3 mRNA level at 100 mg/kg administered for 14 days on day 60 to day 74 post-immunization by RT-qPCR assay2022Journal of natural products, 04-22, Volume: 85, Issue:4
A Natural Plant Ingredient, Menthone, Regulates T Cell Subtypes and Lowers Pro-inflammatory Cytokines of Rheumatoid Arthritis.
AID1866872Antiarthritic activity against collagen-II induced rheumatoid arthritis DBA-1 mouse model assessed as reduction in BMDM Notch2 mRNA level at 100 mg/kg administered for 14 days on day 60 to day 74 post-immunization by RT-qPCR assay2022Journal of natural products, 04-22, Volume: 85, Issue:4
A Natural Plant Ingredient, Menthone, Regulates T Cell Subtypes and Lowers Pro-inflammatory Cytokines of Rheumatoid Arthritis.
AID1866848Antiarthritic activity against collagen-II induced rheumatoid arthritis DBA-1 mouse model assessed as reduction in blood TNF-alpha mRNA level at 100 mg/kg administered for 14 days on day 60 to day 74 post-immunization by RT-qPCR assay2022Journal of natural products, 04-22, Volume: 85, Issue:4
A Natural Plant Ingredient, Menthone, Regulates T Cell Subtypes and Lowers Pro-inflammatory Cytokines of Rheumatoid Arthritis.
AID1866865Antiinflammatory activity against PMA induced DBA-1 mouse spleen CD4+ve Th cells assessed as reduction in TNF-alpha mRNA level at 50 to 100 uM incubated for 24 hrs by RT-qPCR assay2022Journal of natural products, 04-22, Volume: 85, Issue:4
A Natural Plant Ingredient, Menthone, Regulates T Cell Subtypes and Lowers Pro-inflammatory Cytokines of Rheumatoid Arthritis.
AID1866851Antiarthritic activity against collagen-II induced rheumatoid arthritis DBA-1 mouse model assessed as reduction in TNF-alpha protein level at 100 mg/kg administered for 14 days on day 60 to day 74 post-immunization by immunohistochemistry analysis2022Journal of natural products, 04-22, Volume: 85, Issue:4
A Natural Plant Ingredient, Menthone, Regulates T Cell Subtypes and Lowers Pro-inflammatory Cytokines of Rheumatoid Arthritis.
AID1866854Antiarthritic activity against collagen-II induced rheumatoid arthritis DBA-1 mouse blood CD4+ T cells assessed as reduction in Th17 cells differentiation at 100 mg/kg administered for 14 days on day 60 to day 74 post-immunization by flow cytometry analys2022Journal of natural products, 04-22, Volume: 85, Issue:4
A Natural Plant Ingredient, Menthone, Regulates T Cell Subtypes and Lowers Pro-inflammatory Cytokines of Rheumatoid Arthritis.
AID1866856Antiarthritic activity against collagen-II induced rheumatoid arthritis DBA-1 mouse spleen CD4+ T cells assessed as reduction in Th17 cells differentiation at 100 mg/kg administered for 14 days on day 60 to day 74 post-immunization by flow cytometry analy2022Journal of natural products, 04-22, Volume: 85, Issue:4
A Natural Plant Ingredient, Menthone, Regulates T Cell Subtypes and Lowers Pro-inflammatory Cytokines of Rheumatoid Arthritis.
AID1866869Antiarthritic activity against collagen-II induced rheumatoid arthritis DBA-1 mouse model assessed as reduction in damage of articular cartilage at 100 mg/kg administered for 14 days on day 60 to day 74 post-immunization2022Journal of natural products, 04-22, Volume: 85, Issue:4
A Natural Plant Ingredient, Menthone, Regulates T Cell Subtypes and Lowers Pro-inflammatory Cytokines of Rheumatoid Arthritis.
AID1866850Antiarthritic activity against collagen-II induced rheumatoid arthritis DBA-1 mouse model assessed as reduction in blood IL-6 mRNA level at 100 mg/kg administered for 14 days on day 60 to day 74 post-immunization by RT-qPCR assay2022Journal of natural products, 04-22, Volume: 85, Issue:4
A Natural Plant Ingredient, Menthone, Regulates T Cell Subtypes and Lowers Pro-inflammatory Cytokines of Rheumatoid Arthritis.
AID1866868Antiarthritic activity against collagen-II induced rheumatoid arthritis DBA-1 mouse model assessed as reduction in synovial hyperplasia at 100 mg/kg administered for 14 days on day 60 to day 74 post-immunization2022Journal of natural products, 04-22, Volume: 85, Issue:4
A Natural Plant Ingredient, Menthone, Regulates T Cell Subtypes and Lowers Pro-inflammatory Cytokines of Rheumatoid Arthritis.
AID1866873Antiarthritic activity against collagen-II induced rheumatoid arthritis DBA-1 mouse model assessed as reduction in BMDM Delta1 mRNA level at 100 mg/kg administered for 14 days on day 60 to day 74 post-immunization by RT-qPCR assay2022Journal of natural products, 04-22, Volume: 85, Issue:4
A Natural Plant Ingredient, Menthone, Regulates T Cell Subtypes and Lowers Pro-inflammatory Cytokines of Rheumatoid Arthritis.
AID1866867Antiinflammatory activity against PMA induced DBA-1 mouse spleen CD4+ve Th cells assessed as reduction in IL-6 mRNA level at 50 to 100 uM incubated for 24 hrs by RT-qPCR assay2022Journal of natural products, 04-22, Volume: 85, Issue:4
A Natural Plant Ingredient, Menthone, Regulates T Cell Subtypes and Lowers Pro-inflammatory Cytokines of Rheumatoid Arthritis.
AID19262Aqueous solubility2000Bioorganic & medicinal chemistry letters, Jun-05, Volume: 10, Issue:11
Prediction of drug solubility from Monte Carlo simulations.
AID1866858Antiarthritic activity against collagen-II induced rheumatoid arthritis DBA-1 mouse blood CD4+ T cells assessed as reduction in RORgammaT mRNA level at 100 mg/kg administered for 14 days on day 60 to day 74 post-immunization by RT-qPCR assay2022Journal of natural products, 04-22, Volume: 85, Issue:4
A Natural Plant Ingredient, Menthone, Regulates T Cell Subtypes and Lowers Pro-inflammatory Cytokines of Rheumatoid Arthritis.
AID977602Inhibition of sodium fluorescein uptake in OATP1B3-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID1866845Antiarthritic activity against collagen-II induced rheumatoid arthritis DBA-1 mouse model assessed as reduction in serum TNF-alpha level at 100 mg/kg administered for 14 days on day 60 to day 74 post-immunization by ELISA2022Journal of natural products, 04-22, Volume: 85, Issue:4
A Natural Plant Ingredient, Menthone, Regulates T Cell Subtypes and Lowers Pro-inflammatory Cytokines of Rheumatoid Arthritis.
AID1866855Antiarthritic activity against collagen-II induced rheumatoid arthritis DBA-1 mouse spleen CD4+ T cells assessed as reduction in Th1 cells differentiation at 100 mg/kg administered for 14 days on day 60 to day 74 post-immunization by flow cytometry analys2022Journal of natural products, 04-22, Volume: 85, Issue:4
A Natural Plant Ingredient, Menthone, Regulates T Cell Subtypes and Lowers Pro-inflammatory Cytokines of Rheumatoid Arthritis.
AID1866866Antiinflammatory activity against PMA induced DBA-1 mouse spleen CD4+ve Th cells assessed as reduction in IL-1beta mRNA level at 50 to 100 uM incubated for 24 hrs by RT-qPCR assay2022Journal of natural products, 04-22, Volume: 85, Issue:4
A Natural Plant Ingredient, Menthone, Regulates T Cell Subtypes and Lowers Pro-inflammatory Cytokines of Rheumatoid Arthritis.
AID1866857Antiarthritic activity against collagen-II induced rheumatoid arthritis DBA-1 mouse blood CD4+ T cells assessed as reduction in T-bet mRNA level at 100 mg/kg administered for 14 days on day 60 to day 74 post-immunization by RT-qPCR assay2022Journal of natural products, 04-22, Volume: 85, Issue:4
A Natural Plant Ingredient, Menthone, Regulates T Cell Subtypes and Lowers Pro-inflammatory Cytokines of Rheumatoid Arthritis.
AID1866871Antiarthritic activity against collagen-II induced rheumatoid arthritis DBA-1 mouse model assessed as reduction in liver cytochrome P450 level at 100 mg/kg administered for 14 days on day 60 to day 74 post-immunization by ELISA2022Journal of natural products, 04-22, Volume: 85, Issue:4
A Natural Plant Ingredient, Menthone, Regulates T Cell Subtypes and Lowers Pro-inflammatory Cytokines of Rheumatoid Arthritis.
AID1866849Antiarthritic activity against collagen-II induced rheumatoid arthritis DBA-1 mouse model assessed as reduction in blood IL-1beta mRNA level at 100 mg/kg administered for 14 days on day 60 to day 74 post-immunization by RT-qPCR assay2022Journal of natural products, 04-22, Volume: 85, Issue:4
A Natural Plant Ingredient, Menthone, Regulates T Cell Subtypes and Lowers Pro-inflammatory Cytokines of Rheumatoid Arthritis.
AID1866859Antiarthritic activity against collagen-II induced rheumatoid arthritis DBA-1 mouse blood CD4+ T cells assessed as increase in GATA3 mRNA level at 100 mg/kg administered for 14 days on day 60 to day 74 post-immunization by RT-qPCR assay2022Journal of natural products, 04-22, Volume: 85, Issue:4
A Natural Plant Ingredient, Menthone, Regulates T Cell Subtypes and Lowers Pro-inflammatory Cytokines of Rheumatoid Arthritis.
AID1866844Antiarthritic activity against collagen-II induced rheumatoid arthritis DBA-1 mouse model assessed as reduction in clinical score at 100 mg/kg administered for 14 days on day 60 to day 74 post-immunization2022Journal of natural products, 04-22, Volume: 85, Issue:4
A Natural Plant Ingredient, Menthone, Regulates T Cell Subtypes and Lowers Pro-inflammatory Cytokines of Rheumatoid Arthritis.
AID1866864Antiarthritic activity against collagen-II induced rheumatoid arthritis DBA-1 mouse spleen CD4+ T cells assessed as increase in Foxp3 mRNA level at 100 mg/kg administered for 14 days on day 60 to day 74 post-immunization by RT-qPCR assay2022Journal of natural products, 04-22, Volume: 85, Issue:4
A Natural Plant Ingredient, Menthone, Regulates T Cell Subtypes and Lowers Pro-inflammatory Cytokines of Rheumatoid Arthritis.
AID1866862Antiarthritic activity against collagen-II induced rheumatoid arthritis DBA-1 mouse spleen CD4+ T cells assessed as reduction in RORgammaT mRNA level at 100 mg/kg administered for 14 days on day 60 to day 74 post-immunization by RT-qPCR assay2022Journal of natural products, 04-22, Volume: 85, Issue:4
A Natural Plant Ingredient, Menthone, Regulates T Cell Subtypes and Lowers Pro-inflammatory Cytokines of Rheumatoid Arthritis.
AID1866860Antiarthritic activity against collagen-II induced rheumatoid arthritis DBA-1 mouse blood CD4+ T cells assessed as increase in Foxp3 mRNA level at 100 mg/kg administered for 14 days on day 60 to day 74 post-immunization by RT-qPCR assay2022Journal of natural products, 04-22, Volume: 85, Issue:4
A Natural Plant Ingredient, Menthone, Regulates T Cell Subtypes and Lowers Pro-inflammatory Cytokines of Rheumatoid Arthritis.
AID1866852Antiarthritic activity against collagen-II induced rheumatoid arthritis DBA-1 mouse model assessed as reduction in IL-1beta protein level at 100 mg/kg administered for 14 days on day 60 to day 74 post-immunization by immunohistochemistry analysis2022Journal of natural products, 04-22, Volume: 85, Issue:4
A Natural Plant Ingredient, Menthone, Regulates T Cell Subtypes and Lowers Pro-inflammatory Cytokines of Rheumatoid Arthritis.
AID977599Inhibition of sodium fluorescein uptake in OATP1B1-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID1159607Screen for inhibitors of RMI FANCM (MM2) intereaction2016Journal of biomolecular screening, Jul, Volume: 21, Issue:6
A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway.
AID1159550Human Phosphogluconate dehydrogenase (6PGD) Inhibitor Screening2015Nature cell biology, Nov, Volume: 17, Issue:11
6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (124)

TimeframeStudies, This Drug (%)All Drugs %
pre-19906 (4.84)18.7374
1990's9 (7.26)18.2507
2000's43 (34.68)29.6817
2010's48 (38.71)24.3611
2020's18 (14.52)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 51.88

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index51.88 (24.57)
Research Supply Index4.90 (2.92)
Research Growth Index5.06 (4.65)
Search Engine Demand Index81.65 (26.88)
Search Engine Supply Index1.99 (0.95)

This Compound (51.88)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (0.76%)5.53%
Reviews3 (2.27%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other128 (96.97%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]